Argenx
ARGX
#534
Rank
โ‚ฌ36.80 B
Marketcap
601,86ย โ‚ฌ
Share price
-0.35%
Change (1 day)
87.05%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2021 (TTM): -โ‚ฌ0.22 Billion

According to Argenx 's latest financial reports the company's current earnings are โ‚ฌ1.85 Billion. In 2019 the company made an earning of -โ‚ฌ0.18 Billion a decrease over its 2018 earnings that were of -โ‚ฌ75.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM) -โ‚ฌ0.22 Billion
2019 -โ‚ฌ0.18 Billion135.29%
2018 -โ‚ฌ75.33 Million128.48%
2017 -โ‚ฌ32.97 Million46.65%
2016 -โ‚ฌ22.48 Million34.28%
2015 -โ‚ฌ16.75 Million33.49%
2014 -โ‚ฌ12.55 Million48.13%
2013 -โ‚ฌ8.47 Million